QualityStocksNewsBreaks Archives - Page 335 of 1578

TuesdayFeb 06, 2024 12:08 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Discusses MS Trial Results During Latest Proactive Interview

Clene (NASDAQ: CLNN) CEO Rob Etherington was the featured guest on a recent Proactive interview. According to an announcement, Etherington joined Proactive host Steve Darling to discuss recent news the company has released regarding results from its long-term, open-label extension (“LTE”) of the VISIONARY-MS trial. Clene is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”), Parkinson’s disease and multiple sclerosis (“MS”). Etherington and Darling discussed the trial, which involved gathering almost three years of research and information from participants with stable relapsing MS. Darling explained…

MondayFeb 05, 2024 12:58 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on Production and Deliveries, Moves Forward with Production Line Installation

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting “great strides” with the production and deliveries of its Class 1 and Class 3 commercial EVs. In addition, the company is reporting that its subsidiary, Mullen Advanced Energy LLC, "), is moving forward with the installation of its battery-pack production line at its new 122,000-square-foot, high-energy facility in Fullerton, California. The company announced the new facility in November 2023; the new facility is dedicated to producing next-generation, American-made EV battery components, modules and packs. “We are steadfastly focused on production, production, production,” said Mullen Automotive CEO and chair…

MondayFeb 05, 2024 12:39 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Phase2a Expansion of Acclaim-1 Clinical Study Enrolls, Doses First Patient

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has enrolled and dosed the first patient in the phase 2a expansion portion of its Acclaim-1 clinical study of Reqorsa(R) therapy (quaratusugene ozeplasmid). The study combines Genprex’s proprietary lead product candidate with AstraZeneca's Tagrisso(R) to treat patients with late-stage non-small cell lung cancer (“NSCLC”). An open-label, multicenter phase 1/2 clinical trial, the Accliam-1 trial has completed its phase 1 component and is moving on to phase 2. The company anticipates enrolling an estimated 66 patients in phase 2a, with one-half of the study participants…

MondayFeb 05, 2024 12:32 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Bringing Tried and Tested Solutions to Governments Worldwide

SuperCom Ltd. (NASDAQ: SPCB) is a leading global provider of traditional and digital identity solutions offering advanced safety, identification, and security products and solutions to governments. The company is proactively advancing its offender electronic monitoring solutions and services. “SuperCom offers government agencies a way to protect the victims of domestic abuse without the necessity of prolonged and expensive incarceration through advanced electronic monitoring. Since 1988, SuperCom has refined its offerings, yielding several offender monitoring solutions under its PureSecurity(TM) line, such as PureTrack(TM), PureCom(TM), PureTag(TM), PureProtect(TM), and PureBeacon(TM). These are in addition to its PureMonitor(TM) cloud-based software platform designed to deliver…

MondayFeb 05, 2024 12:27 pm

QualityStocksNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Inks Exclusive Agreement with Singapore-Based Distributor, Includes Evolve(TM) Soft Bait Orders

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations, has entered a distribution agreement with a leading Singapore-based pest-control product manufacturer and distributor: Agro Technic PTE Ltd. According to the announcement, the agreement includes a significant initial stocking order as well as annual minimums. The product range that SenesTech provides is a “perfect fit” for the Agro Technic business model, long-term strategy and market positioning, according to Agro Technic. The company is committed to offering market solutions that are both environmentally friendly but effective. “Agro Technic is a leading manufacturer and supplier for equipment and chemicals in Singapore,…

MondayFeb 05, 2024 12:12 pm

QualityStocksNewsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Upcoming Launch and Expansion of OPKO Health-Branded Storefront

NextPlat (NASDAQ: NXPL, NXPLW), a global e-Commerce provider, is preparing for the launch of its exclusive OPKO Health-branded storefront on Alibaba Group Holding Limited's ("Alibaba")(NYSE: BABA) Tmall Global in China. The move follows the company’s receipt of the initial set of approvals required to operate the store in the country. “We are pleased to reach this strategic milestone with our partners OPKO and Alibaba because we believe in the global potential of health and wellness as millions of consumers in China and around the globe continue to prioritize their wellbeing, contributing to the continued growth of this large and valuable…

FridayFeb 02, 2024 3:45 pm

QualityStocksNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) on Track to Supply OEMs with Rare Earth Oxides by 2025

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is engaged in the exploration for and separation and scalable production of REEs in Canada and the U.S. The company is positioning for ultimate commercialization its RapidSX(TM) technology for the separation and purification of critical metals, a move that would slash reliance on Chinese rare earth technologies and its byproducts. “Ucore has gained incredible headway over the years, made possible by the funding from the Pentagon. The company is on track to commercially separate friendly sources of REEs and supply OEMs with rare earth oxides (‘REOs’) required to produce rare earth permanent magnets…

FridayFeb 02, 2024 3:15 pm

QualityStocksNewsBreaks – Sekur Private Data Ltd.’s (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0) Solutions Suite Designed to Offer Maximum Cyber Protection

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0) provides a suite of cybersecurity and internet security services that enable businesses and individuals to communicate online safely without the threat of breaches and offers Swiss-based servers for maximum protection. “Sekur’s full suite of cybersecurity and internet privacy services include SekurMail with the SekurSend/SekurReply feature, SekurVPN, and SekurMessenger – greatly eliminating the chance of a cyber breach,” a recent article reads. “Sekur’s suite of services is available to businesses and individuals on a subscription basis, and all subscribers’ electronic communications are through Sekur’s owned and maintained data servers in Switzerland, a…

FridayFeb 02, 2024 2:45 pm

QualityStocksNewsBreaks – Mountain Top Properties Inc. (MTPP) Positioning to Drive Real Estate Development Plans, Expand Tech-Driven Business

Mountain Top Properties (OTC: MTPP), a diversified real estate holding company, is seeking to raise up to $10 million in gross proceeds from a Regulation A offering. The company intends to deploy the proceeds to support its real estate development plans within the exclusive Hamptons real estate market. “In addition, the company is planning to expand on its technologically driven property management business centered on the larger Northeastern U.S. region. Through its Mountain Top Capital Fund I, Mountain Top Realty has sought to raise $75 million to build, acquire, renovate, and remarket homes in the Hamptons; thus far, the fund…

FridayFeb 02, 2024 12:27 pm

QualityStocksNewsBreaks – Clene Inc.’s (NASDAQ: CLNN) CNM-Au8 Produces ‘Significant and Very Promising Effect’ in Parkinson’s, MS Patients

Clene’s (NASDAQ: CLNN) lead drug candidate CNM-Au8 was the subject of two Phase 2a clinical trials, REPAIR-PD and REPAIR-MS, which evaluated the effects of CNM-Au8 on brain energy metabolite levels in participants with diagnoses of idiopathic Parkinson’s Disease (“PD”) and relapsing Multiple Sclerosis (“MS”), respectively. The REPAIR-PD and REPAIR-MS Phase 2 trials expanded the documented evidence of CNM-Au8’s positive effects demonstrated by in vitro studies, which have shown that the surfaces of the drug candidate’s nanocrystals catalyze the rapid oxidation of NADH to NAD+, increasing the intracellular availability of both NAD+ and ATP. NAD+ supports the synthesis of ATP, the…

Site Search

Company Search

Category: QualityStocksNewsBreaks